Fibrolamellar Carcinoma: What Is New and Why It Matters.
Sign Up to like & getrecommendations! Published in 2018 at "Surgical pathology clinics"
DOI: 10.1016/j.path.2018.02.006
Abstract: Fibrolamellar carcinoma is distinctive at clinical and histologic levels. A novel DNAJB1-PRKACA fusion gene characterizes almost all cases, distinguishes it from other hepatocellular neoplasms, and drives the pathogenesis of this unique tumor. A subset of… read more here.
Keywords: carcinoma new; fibrolamellar carcinoma; new matters; pathology ... See more keywords
Metastatic medullary thyroid carcinoma: a new way forward
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine-Related Cancer"
DOI: 10.1530/erc-21-0368
Abstract: Medullary thyroid carcinoma (MTC) is a rare malignancy comprising 1–2% of all thyroid cancers in the United States. Approximately 20% of cases are familial, secondary to a germline RET mutation, while the remaining 80% are… read more here.
Keywords: thyroid carcinoma; carcinoma new; new way; medullary thyroid ... See more keywords
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14010041
Abstract: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death and is associated with a dismal median survival of 2–9 months. The fundamental limitations and ineffectiveness of current HCC treatments have led to the… read more here.
Keywords: cancer; carcinoma new; hepatocellular carcinoma; treatment ... See more keywords